Angiotensin-converting enzyme (ACE) inhibitors (ACEIs) and angiotensin II type‐1 receptor blockers (ARBs) are among the most widely prescribed drugs for the treatment of arterial hypertension, heart failure and chronic kidney disease. This evidence concerns the gene ACE and heart failure.